From: ncbi-seminar-admin@ncbi.nlm.nih.gov on behalf of Michael Galperin [galperin@ncbi.nlm.nih.gov] Sent: Thursday, February 27, 2003 3:12 PM To: ncbi-seminar@ncbi.nlm.nih.gov Subject: CBB seminar March 4th Pushing the (cell) envelope: Studies of surface-exposed bacterial proteins Michael Galperin Tuesday, March 4th, 11:00 am, Bldg. 38A, 5th floor conference room, Surface-exposed (extracytoplasmic) proteins participate in the interaction of bacteria with the environment and define their specific antigenic properties. As a result, such proteins typically exhibit higher diversity then the cytoplasmic proteins and do not necessarily fit into the existing protein families (COGs, CDDs). Nevertheless, rapid growth of the list of completely sequenced bacterial genomes brings into the database homologs of many extracytoplasmic proteins and allows their comparative analysis. Our studies of surface-exposed proteins centered on three groups of proteins: (i) proteins involved in the Na+ cycle (generation and maintenance of the sodium-motive force); (ii) signal transduction proteins with periplasmic or integral membrane sensory domains; (iii) surface-anchored proteins of Streptococcus pneumoniae. I will describe several interesting domains, delineated in the course of these studies, and discuss the following ideas brought about by this analysis: (i) The choice between Na+- and H+-dependent energetics seems to depend on the aerobic/anaerobic lifestyle of the organism, rather than on it being a bacterium or an archaeon, its growth temperature or pathogenicity. (ii) Association of certain conserved sensory domains with various signal output domains allows microorganisms to sense the environmental signals (e.g., pH, osmolarity) and transmit this information to different regulatory circuits: transcriptional regulation, chemotaxis, catabolite repression, and production of extracellular factors. (iii) The pneumococcal cell envelope contains a number of surface proteins with various enzymatic activities, some of which (but not all) can be interesting vaccine candidates.